Laboratory models by the team of Sikiric et al
KLOW for Anti-Aging and Recovery When we think about anti-aging, we often focus on what we see in the mirror
Researchers aren't exactly clear why the drug appears to work better in people with overweight or obesity (but not diabetes) compared to people with diabetes who also have overweight or obesity
Abstract Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin wound therapy, incisional/excisional wound, deep burns, diabetic ulcers, and alkali burns, which may be generalized to the other tissues healing
Injections are more effective for those with absorption issues or severe deficiencies, while pills may suffice for mild deficiencies
These barriers complicate redox-focused cellular investigations and translational modeling